Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-07-18

Clinical Trial Update: Hyaluronic Acid and Adelmidrol (Hyadrol®) in Patients With Degenerative Joint Disease [NA]

View source ↗

Summary

A clinical trial is evaluating Hyadrol, a combination of hyaluronic acid and adelmidrol, for degenerative joint disease and is currently recruiting at the Unive…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hyadrol (Hyaluronic acid and adelmidrol combination)

Snippet

Sponsor: University of Roma La Sapienza | Conditions: Degenerative Joint Disease | NA | Status: RECRUITING